Lovastatin, an inhibitor of HMG-CoA reductase, was produced by solid state fermentation (SSF) using a strain of Aspergillus terreus UV 1718. Different solid substrates and various combinations thereof were evaluated for lovastatin production. Wheat bran supported the maximum production (1458 ± 46 µg g 
INTRODUCTION
Lovastatin, a potent drug for lowering blood cholesterol, competitively inhibits the rate-limiting enzyme of cholesterol biosynthesis, 3-hydroxy-3methyl glutaryl coenzyme A (HMGCoA) reductase (1) . Besides, it has clear beneficial evidence on stroke and it has shown in vivo tumor suppression by inhibiting the synthesis of non-sterol isoprenoid compounds (9, 16) .
Lovastatin was the first statin to be approved by US FDA as a hypocholestremic drug (13) . Although several microorganisms have been reported to produce lovastatin, only strains of A.
terreus have been successfully implemented for large-scale production (10) and most of the literature deals with this species (5, 7, 17) . However, Szakacs et al. (20) explored the possibility of lovastatin production from SSF by screening various strains of Aspergillus species for production of lovastatin in SSF and submerged fermentation (SmF). Lian et al. (12) used rice as a substrate for production of lovastatin by SSF. Lovastatin production by SSF using Monscus. purpureus CCRC 31615 (19) , M. purpureus NTU 601 (21) , M. pilosus M12-69 (6) , and M. ruber (22) , are also reported in literature.
The application of statistical experimental design techniques in fermentation process development can result in improvement of product yield, reduce process variability, give closer confirmation of the output response to nominal and reduce overall costs. Conventional practice of single factor reduce optimization by maintaining other factors involved at an unspecified constant level does not depict the combined effect of all the factors involved. This method is also time consuming and requires a number of experiments to determine optimum levels, which are unreliable. These limitations can be eliminated by optimizing all the affecting parameters collectively by RSM. RSM can be used to evaluate the relative significance of several factors even in the presence of complex interactions (3, 15) . There are also some reports on RSM optimization of submerged fermentation using A. terreus
There is scarcity of literature on production of lovastatin by SSF using A. terreus. Moreover, SSF is advantageous due to low production cost and high productivity. The present work investigates screening of different solid substrates for the production of lovastatin by SSF followed by optimization of the inoculum size. Subsequently RSM was applied to optimize media components and culture conditions. 
MATERIALS AND METHODS

Microorganism and media components
Influence of various substrates on lovastatin production
Experiments were performed using different solid substrates like agricultural wastes (wheat bran, corn hull and rice husk), fruit juice wastes (sugarcane bagasse, orange peel and orange pulp) and edible oil industries waste (cottonseed oil cake and groundnut oil cake) to check their suitability for lovastatin production. Different cake combination of these substrates was also evaluated such as wheat bran and corn hull 
Media optimization by response surface methodology (RSM)
Experimental design was formulated according to central (14) .
The relative effects of two variables on response were identified from three dimensional plots. An optimum value of the variables for maximum production of lovastatin was determined by point prediction tool of the software. 
Effect of supplementation of carbon and nitrogen sources
To further enhance the production of lovastatin various carbon (glucose, lactose, sucrose, and soluble starch at a concentration of 1% w/w) and nitrogen sources (yeast extract, soybean meal, mycological peptone and malt extract at a concentration of 1% w/w) were added to the RSM optimized medium, properly mixed and incubated for 3 days.
HPLC analysis
Lovastatin Lovastatin and hydroxy acid lovastatin in the clear supernatant was estimated by HPLC as described earlier.
RESULTS AND DISCUSSION
Influence of various substrates on lovastatin production
The use of inexpensive substrates for the production of lovastatin has combined benefit of utilizing a low-grade substrate while producing a commercially valuable product.
Wheat bran yielded maximum lovastatin of 1458 ± 46 µg g -1 of dried fermented matter (DFM) among all substrates used (Fig.   1) ; this result is in accordance with that of Szakacs et al. (20) who also found wheat bran to be a suitable substrate for O r a n g e P e e l a n d P u l p S u g a r C a n e B a g g a s e
Lovastatin µg/g DFM was obtained just after day 3 of incubation ( Fig. 2 ). There was a rapid rise in lovastatin production between days 2 and 3, after which the lovastatin concentration gradually fell up to day 6 and thereafter remained almost constant until day 10 of fermentation. 
Determination of optimum inoculum size
A spore count of 5 × 10 7 spore mL -1 (20% v/w) was found to be optimum with the production of 1845 ± 38 µg g -1 DFM of lovastatin (Fig. 3 ). Higher inoculum size decreased the lovastatin production marginally. 
Media Optimization by RSM
The individual and interactive effects of these nutrient variables were studied by conducting the fermentation runs at randomly selected different levels of all four parameters. The response was measured in terms of lovastatin production. The results of experimental data and predicted by quadratic model are listed in Table 2 . The ANOVA of the quadratic model shows the model F-value of 13.89 (Table 3 Coefficient of correlation (RAccordingly, three dimensional graphs were generated for the pair-wise combination of the four factors, while keeping the other two at their center point levels. Graphs are given here to highlight the roles played by various factors. This model resulted in five response surface graphs. The response surface plots of significant factors for lovastatin production are shown in Fig. 4 (a, b and c) . The proposed model equation illustrates the interaction between two factors; from the equation it was found that % moisture content interacted positively with trace ion concentration and particle size, whereas trace ion concentration, particle size and K 2 HPO 4 showed negative interaction with respect to lovastatin production. From Fig. 4 (a, b) it is evident that too high and too low % moisture and particle size gave less growth and lower lovastatin production.
This phenomenon can be explained by increased voidage volume and decreased surface area with increasing particle size and vice versa. As the moisture content increases, the air present in the void volume decreases, resulting in poor oxygen availability in the processes without forced aeration.
Consequently, a certain combination of particle size and moisture content gives the best result in terms of lovastatin yield and biomass. In case of higher particle size, voidage is higher. Hence, the amount of trapped air is also higher but the substrate available is however lesser because the exposed surface area is lower. With lower moisture content (50%), the available oxygen is sufficient, but the water content is not enough to support good metabolic activity and dissipation of the heat generated. This may account for lower lovastatin production and biomass. As the moisture level increased from 60 to 70%, air present in the void volume was replaced by water, resulting in decrease of available oxygen. Lovastatin content as well as biomass increased when the moisture level increased from 60 to 70%. This may be because of the adequate amount of oxygen and water present within the substrate bed to support good fungal growth and removal of metabolic heat. However, when the moisture level was increased from 80 to 90%, biomass as well as lovastatin content decreased. This is presumably due to poor oxygen availability caused by excessive replacement of air by water in the voidage volume. In the present study, the optimum particle size, was found to be 0.35 mm rather 0.175 mm. At lower particle size, the particles are too densely packed with lower voidage volume which retards the oxygen transfer and also increases the localized heat generation in the bed of the solid substrate. This eventually lowers both the growth and lovastatin production.
Effect of supplementation of carbon and nitrogen sources
Nature and type of carbon and nitrogen sources are among the most important factors for any fermentation process.
Organic nitrogen sources are rich in protein and sources of amino acid to the organism. Amino acids are very important for biosynthesis of lovastatin (13) . The effect of additional complex organic sources at 1% w/w on lovastatin production is shown in Fig. 5 . Mycological peptone and yeast extract yielded higher lovastatin 3723.4±49 and 3405.2±42 µg g -1 DFM, respectively as compared to control. It is indicated that wheat bran alone may not be sufficient to provide nitrogen source.
Hence additional nitrogen source was thought to be essential for enhancement of lovastatin production. None of the carbon sources used could increase production of lovastatin. Glucose, lactose and sucrose decreased the yield of lovastatin to 2101±51, 2534±29 and 2435±38 µg g -1 DFM, respectively.
This could be either due to inhibition of the product formation or catabolic repression, the exact mechanism not being known.
This warrants further work to establish the mechanism of inhibition.
The production of lovastatin increased 2.6 fold to 
CONCLUSION
The results obtained in the present paper reveal the potential of SSF as an alterative to the submerged fermentation for the production of lovastatin by using strain of A. terreus UV 1718. To the best of our knowledge the yield reported is the highest by strain of A. terreus using SSF.
